Differential Diagnoses for Painless, Progressive Breast Mass

Clinical Context and Diagnostic Approach

The American College of Radiology and the National Comprehensive Cancer Network recommend a systematic evaluation through the triple test approach (clinical examination, imaging, and tissue biopsy) for a painless, progressively enlarging breast mass in a young female without systemic symptoms, nipple changes, or skin alterations 1, 2

Phyllodes tumors can present identically to fibroadenoma with a painless, progressively enlarging mass, and tends to grow more rapidly than typical fibroadenomas, though benign variants can have slower growth, according to the National Comprehensive Cancer Network 3
Invasive ductal carcinoma must be considered given the progressive nature and 2-year duration, and can present as a painless mass without associated nipple discharge, skin changes, or systemic symptoms, as stated by the National Comprehensive Cancer Network 2
The National Comprehensive Cancer Network and the American College of Radiology recommend tissue diagnosis as imaging alone cannot definitively exclude malignancy, and the absence of metastatic symptoms does not exclude early-stage breast cancer 1, 2, 4
Approximately 10% of ductal carcinoma in situ (DCIS) presents as a palpable mass without calcifications on mammography, and can present without nipple discharge, skin changes, or systemic symptoms, according to the American Cancer Society 5, 6
DCIS cannot be distinguished from invasive cancer by imaging alone; requires histopathologic examination, as stated by the American Cancer Society 5, 6

The American College of Radiology recommends ultrasound of the breast and axilla as initial imaging, and diagnostic mammography to provide global breast assessment and detect any associated calcifications 1, 8, 2
The National Comprehensive Cancer Network recommends core needle biopsy (not fine-needle aspiration) for definitive tissue diagnosis with assessment of hormone receptors and HER2 status if malignancy is found 2, 7